This implicates that the per se low PTEN expression in bone metastasizing RCC cells is further reduced by the bone microenvironment, consequently activating the AKT signaling pathway and promoting bone metastasis (Figure 6). The gene discussed is AKT1; the disease is renal cell carcinoma.